PHARMALAB ApS: Financial statements 2022
CVR: 33058101
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PHARMALAB ApS (CVR 33058101) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 8,548 and a net result of DKK -16,738 compared with DKK -23,848 the year before. Equity in the 2022 report amounted to DKK -76,084. The company had 1 employee in the financial year.
- Gross Profit
- DKK 8,548
- Profit/Loss
- DKK -16,738
- Equity
- DKK -76,084
- Total Assets
- DKK 999,248
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 9 t. | -17 t. | -76 t. | 1 |
| 2021 | - | -17 t. | -24 t. | -59 t. | - |
| 2020 | - | -10 t. | -8 t. | -35 t. | - |
| 2019 | - | -28 t. | -23 t. | -27 t. | - |
| 2018 | - | -138 t. | 286 t. | -5 t. | - |
Official annual report
Keep an eye on PHARMALAB ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PHARMALAB ApS has published its annual report for 2021. Gross profit came to DKK -17,376, and the net result was DKK -23,848.
As of July 12, 2022, Cedra Godkendt Revisionsaktieselskab has stepped down as auditor of PHARMALAB ApS.
About PHARMALAB ApS
PHARMALAB ApS was a Danish company of the type Anpartsselskab based in Hårlev, founded in 2010. The company has been dissolved on 18 March 2025. The company was registered under the industry Fremstilling af andre maskiner til generelle formål i.a.n.. According to the 2023 annual report, the company had an average of 1 employee. In 2023, the company reported a gross profit of DKK -42,256 and a net result of DKK -31,505 compared with DKK -16,738 the year before. Equity in the 2023 report amounted to DKK -107,589.